Roche Holding AG (OTCQX International Premier:RHHBY)

29.75
Delayed Data
As of Feb 23
 -0.10 / -0.34%
Today’s Change
28.48
Today|||52-Week Range
36.82
-5.79%
Year-to-Date
Shionogi's Single-Dose Flu Drug Gets Japanese Approval
Feb 23 / TheStreet.com - Paid Partner Content
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan
Feb 16 / Zacks.com - Paid Partner Content
Will Mylan (MYL) Disappoint Investors This Earnings Season?
Feb 22 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock
Feb 15 / Zacks.com - Paid Partner Content
Will Cabometyx Fuel Exelixis' (EXEL) Earnings in Q4 Again?
Feb 21 / Zacks.com - Paid Partner Content
Prothena's (PRTA) Loss Narrows in Q4, Pipeline Progresses
Feb 15 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock (Revised)
Feb 16 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets Priority Review for Label Expansion
Feb 14 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion
Feb 16 / Zacks.com - Paid Partner Content
Exelixis Reports Positive Data From Thyroid Carcinoma Trial
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.85
Today’s open29.61
Day’s range29.51 - 29.79
Volume810,072
Average volume (3 months)1,950,566
Market cap$165.1B
Data as of 3:59pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-9.89%
Earnings growth (this year)+12.12%
Earnings growth (next 5 years)+5.70%
Revenue growth (last year)+5.48%
P/E ratio17.2
Price/Sales4.01
Price/Book7.49

Competitors

No competitors data available.

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$54.2B
Annual profit (last year)$8.8B
Net profit margin16.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts